News

Please note the Randomisation phoneline will be closed from 5pm on 23rd December until 2nd Jan and will reopen at 9am on 3rd January 2017...

October 2016 marks one year since the Add-Aspirin trial opened to recruitment across the UK. Since then 150 hospitals have chosen to participate with the 1000th patient randomised as of 12th October 2016, making it the largest randomised controlled trial to examine the relationship between cancer and aspirin...

On July 15th the 1000th patient was registered to Add-Aspirin. We would like to thank all sites across the UK for your hard work in reaching this milestone in the trial...

The MRC CTU at UCL will be hosting four regional Urological Trials meetings to highlight various aspects of urological trials within the Unit, during which there will be a talk from the Add-Aspirin Chief Investigator, Professor Ruth Langley...

The Self-evident corrections, or SECs, are specific situations where data given on CRFs will be corrected by the trial team when entered on the database. These are very useful for sites as it means you, the site, will not be notified of these queries, nor will sites need to confirm these corrections...